Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma.
Pipas JM, Zaki BI, McGowan MM, Tsapakos MJ, Ripple GH, Suriawinata AA, Tsongalis GJ, Colacchio TA, Gordon SR, Sutton JE, Srivastava A, Smith KD, Gardner TB, Korc M, Davis TH, Preis M, Tarczewski SM, MacKenzie TA, Barth RJ Jr.
Pipas JM, et al. Among authors: ripple gh.
Ann Oncol. 2012 Nov;23(11):2820-2827. doi: 10.1093/annonc/mds109. Epub 2012 May 9.
Ann Oncol. 2012.
PMID: 22571859
Free PMC article.
Clinical Trial.